ReviewJournal of immunology research2025
Immunomodulatory Mechanisms and Therapeutic Potential of Vitamin D in Immune Thrombocytopenia.
Review in Journal of immunology research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Immunomodulatory Mechanisms and Therapeutic Potential of Vitamin D in Immune Thrombocytopenia.Journal of immunology research · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In addition to its classical function in regulating phosphorus and calcium equilibrium, the immunoregulatory effects of vitamin D (VD) have increasingly drawn attention in recent investigations. A deficiency of VD has been associated with multiple autoimmune pathologies. Immune thrombocytopenia (ITP), a hemorrhagic disorder mediated by autoantibodies, manifests through accelerated platelet destruction accompanied by impaired platelet production. Accumulating evidence suggests that VD is intricately involved in ITP pathophysiology, with serum VD concentrations strongly associated with clinical symptoms, disease severity, and overall prognosis. However, the mechanisms underlying these associations remain incompletely understood, and the limited number of studies conducted thus far highlights the necessity for further investigation. This study reviews the correlation between VD and ITP, the immunological mechanisms through which VD regulates ITP, and the potential therapeutic value of VD supplementation in ITP management. Future multicenter clinical trials and mechanistic studies are warranted to develop novel therapeutic strategies for ITP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.